1694.8000 -6.70 (-0.39%)
NSE May 02, 2025 15:31 PM
Volume: 35,634
 

1694.80
-0.39%
Emkay
MHL’s Q3FY25 EBITDA missed street/our estimates by 9%/4%, with revenue growing 11% YoY driven by B2C revenue improving 15% YoY.
Metropolis Healthcare Ltd. is trading below its 100 day SMA of 1799.1
More from Metropolis Healthcare Ltd.
Recommended